CAS 1022958-60-6

CEP-28122

Description:

CEP-28122, identified by its CAS number 1022958-60-6, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to exhibit properties that may influence various biological pathways. The compound's structure includes specific functional groups that contribute to its activity, although detailed information about its mechanism of action may still be under investigation. CEP-28122 has been studied for its effects on certain diseases, and its pharmacokinetic and pharmacodynamic profiles are essential for understanding its efficacy and safety in clinical settings. As with many investigational compounds, ongoing research aims to elucidate its full range of characteristics, including solubility, stability, and interaction with biological targets. Overall, CEP-28122 represents a promising candidate in the realm of medicinal chemistry, with the potential for further development in therapeutic applications.

CEP-28122

CAS: 1022958-60-6

CEP-28122

Molecular weight: 539.07g/mol

Ref: 54-BUP00260

CEP-28122

CAS: 1022958-60-6

CEP-28122 is a highly potent and selective orally active ALK inhibitor.

Formula: C₂₈H₃₅ClN₆O₃

Purity: 99.87% - >99.99%

Color and Shape: Solid

Molecular weight: 539.07

Ref: TM-T2612

CEP-28122

Controlled Product

CAS: 1022958-60-6

Applications CEP-28122 is used as an orally efficacious inhibitor of (ALK), analplastic lymphoma kinase, in the treatment of cancer.
References Gingrich, D. et al.: J. Med. Chem., 55, 4580 (2012);

Formula: C₂₈H₃₅ClN₆O₃

Color and Shape: Neat

Molecular weight: 539.069

Ref: TR-C256650

CEP-28122

CAS: 1022958-60-6

CEP-28122 is a selective and potent small-molecule inhibitor, which is derived from chemical synthesis targeting receptor tyrosine kinases, specifically the fibroblast growth factor receptors (FGFRs). Its mode of action involves the competitive inhibition of ATP binding, thereby preventing the phosphorylation cascade necessary for signal transduction downstream of FGFRs. By inhibiting these pathways, CEP-28122 effectively impedes processes such as cell proliferation and angiogenesis, which are critical in various pathological conditions including cancer.

Formula: C₂₈H₃₅ClN₆O₃

Purity: Min. 95%

Molecular weight: 539.07 g/mol

Ref: 3D-XQB95860